ENGN enGene Holdings Inc Revenue Growth QoQ

ENGN (enGene Holdings Inc) - company brandmark

Quarterly revenue growth for enGene Holdings Inc. (ENGN) demonstrates volatility, as the absence of commercial products and reliance on external funding render cash flows unpredictable. The 0.00 mark characterizes this parameter, while the market has already priced in current losses and the anticipation of patent data regarding cancer treatment. The valuation is fundamentally supported by a high scientific reputation in the development of safe gene vectors.

ENGN (enGene Holdings Inc) Revenue Change vs Previous Quarter history from 02/21/2024 to 11/21/2026

Financial and market metric breakdowns for enGene (ENGN)

- stock price and consensus target price:
- market capitalization data:
Basic company analysis:enGene Holdings Inc. - ENGN
Mass-produced product of engene.com

This metric is calculated as the percentage change in current quarter revenue relative to the same period last year, measuring the pace of business expansion. This metric identifies a fading operational momentum, warning the investor of the risk of capital stagnation before a shift in the market cycle. For enGene Holdings Inc. (ENGN), sales growth confirms the commercial demand for the non-viral DEP platform in cancer therapy. By analyzing the percentage increase in quarterly sales, one can assess the effectiveness of the implementation of mucosal drugs.

Competing companies

argenx BVBA - Quarterly Revenue Growth|BNTX: Revenue Growth QoQ|ABVX: Quarterly Revenue Growth|Sales Growth QoQ ADMA|Revenue Growth QoQ protagonist-inc.com|Quarterly Sales Growth Immunovant, Inc. (IMVT)|Quarterly Revenue Growth KNSA|GRFS: Revenue Dynamics QoQ|Adaptive Biotechnologies - Quarterly Sales Growth|CLDX: Sales Growth QoQ|Aurinia Corp - Quarterly Revenue Growth|Quarterly Revenue Growth Rate BioCryst Corp|VERA: Quarterly Revenue Growth|dianthustx.com (DNTH) - Quarterly Revenue Growth|PHVS (Pharvaris NV) - Quarterly Revenue Growth|ABCL: Quarterly Revenue Increase|Revenue Growth QoQ Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Quarterly Revenue Increase|Quarterly Revenue Growth PHAR (Pharming Corp)|nektar.com (NKTR) - Quarterly Revenue Growth Rate|UPB - Revenue Growth QoQ|Quarterly Revenue Increase ZBIO (Zenas Biopharma)|IMNM: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Gossamer Bio, Inc. (GOSS)|Revenue Growth QoQ KalVista Pharmaceuticals|Septerna Inc (SEPN) - Quarterly Sales Growth Rate|Quarterly Revenue Growth PVLA|SVRA (Savara) - Quarterly Revenue Increase|Rigel Pharma - Quarterly Sales Growth|Quarterly Sales Growth Rate AnaptysBio Corp (ANAB)|ATXS: Quarterly Sales Growth|RAPT Therapeutics Inc. (RAPT) - Quarterly Sales Growth|JBIO (Aerovate Therapeutics) - Quarterly Sales Growth|ACRS: Sales Change QoQ|KYTX (Kyverna Therapeutics, Inc) - Quarterly Revenue Growth|Sales Growth QoQ TLSA (Tiziana Life Sciences PLC)|Quarterly Revenue Growth CABA|Revenue Growth QoQ VTYX (Ventyx Biosciences, Inc.)|Revenue Growth QoQ Theratechnologies Inc THTX|Quarterly Sales Growth Rate Avalo Therapeutics, Inc. (AVTX)|ELDN - Revenue Growth QoQ|AGEN - Quarterly Revenue Growth|climbbio.com (CLYM) - Revenue Growth QoQ|Zura Bio - Quarterly Revenue Increase|ATYR (atyrpharma.com) - Quarterly Revenue Growth|Sales Growth QoQ ADAG (Adagene)|Quarterly Revenue Growth IMA|STTK (Shattuck Labs) - Quarterly Revenue Increase|Equillium Inc - Quarterly Sales Growth|Quarterly Revenue Increase CNTB|IMUX - Revenue Growth QoQ|Revenue Dynamics QoQ ATRA|IFRX (InflaRx) - Quarterly Sales Growth|X4 Pharma (XFOR) - Quarterly Revenue Growth|ACET (Adicet) - Quarterly Revenue Growth|Quarterly Sales Growth celularity.com (CELU)|Revenue Growth QoQ INmune Bio Inc (INMB)|Quarterly Sales Growth Rate Barinthus Biotherapeutics PLC|Revenue Growth QoQ Kezar Life Sciences Inc KZR|Quarterly Revenue Increase SABS|AKTX - Revenue Growth QoQ|Quarterly Revenue Increase ENLV (enlivex.com)|QTTB: Quarterly Revenue Growth|Sales Growth QoQ GOVX|Quarterly Sales Growth EDSA|Sales Growth QoQ IBIO (iBio Corp)|Revenue Growth QoQ Carisma Therapeutics Inc (CARM)|Quarterly Sales Growth Rate xtlbio.com|Bolt Biotherapeutics Inc. - Quarterly Sales Growth|HCW Biologics Inc (HCWB) - Quarterly Revenue Growth Rate|Aptevo - Quarterly Revenue Growth|AIM ImmunoTech (AIM) - Quarterly Sales Growth|Aditxt Corp (ADTX) - Revenue Growth QoQ|Sales Growth QoQ GRI|Quarterly Sales Growth XRTX|Quarterly Revenue Growth Rate Vyome Holdings Inc. HIND|Quarterly Revenue Growth REVB|Quarterly Sales Growth Rate Indaptus Corp|BiondVax Pharmaceuticals - Quarterly Sales Growth|CalciMedica Corp (CALI) - Quarterly Revenue Growth Rate|Affimed - Quarterly Revenue Growth|Quarterly Sales Growth Rate allakos.com ALLK|HOOKIPA Pharma (HOOK) - Revenue Growth QoQ|IGMS (IGM Biosciences Inc.) - Revenue Growth QoQ|ITOS (iTeos Therapeutics) - Quarterly Revenue Growth|Sales Growth QoQ OCEA (Ocean Biomedical)|Revenue Growth QoQ TC Biopharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Quarterly Revenue Increase